Literature DB >> 29136342

Direct intranasal application of the solid phase of ImmunoCAP® increases nasal specific immunoglobulin E detection in local allergic rhinitis patients.

Paloma Campo1, María Del Carmen Plaza-Seron2, Ibon Eguiluz-Gracia1, Jesús Verge3, Luisa Galindo1, Esther Barrionuevo1, Javier Fernandez4, Raquel Jurado2, Cristobalina Mayorga2, María José Torres1, Carmen Rondón1.   

Abstract

BACKGROUND: The measurement of nasal specific IgE (NsIgE) in local allergic rhinitis (LAR) patients is challenging and shows variability. The objective of this work was to evaluate a minimally-invasive method of direct detection of NsIgE in patients with LAR to Dermatophagoides pteronyssinus (DP) using an automated immunoassay.
METHODS: Fifty patients participated (LAR, n = 14; allergic rhinitis (AR), n = 20; healthy controls [HC], n = 16). Detection of NsIgE was performed by direct application of the solid phase of a commercial DP ImmunoCAP® test 24 hours after DP nasal provocation.
RESULTS: There was no difference in the median volume of secretion absorbed by the solid phase of the ImmunoCAP test in the 3 studied groups (p = 0.17). According to receiver operating characteristic (ROC) curve analysis, NsIgE ≥0.1450 was the optimal cutoff point, obtaining in LAR patients 42.86% sensitivity with the highest specificity (100%), and 75% sensitivity and 100% specificity for AR.
CONCLUSION: This study demonstrates the detection of NsIgE to DP in LAR by using a simple, commercial device with high specificity.
© 2017 ARS-AAOA, LLC.

Entities:  

Keywords:  local; nasal; rhinitis; sensitivity; specific IgE

Mesh:

Substances:

Year:  2017        PMID: 29136342     DOI: 10.1002/alr.22039

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  6 in total

Review 1.  IgE Test in Secretions of Patients with Respiratory Allergy.

Authors:  Carmen Rondón; Ibon Eguíluz-Gracia; Mohamed H Shamji; Janice A Layhadi; María Salas; María José Torres; Paloma Campo
Journal:  Curr Allergy Asthma Rep       Date:  2018-10-13       Impact factor: 4.806

2.  Nasal specific IgE to Der p is not an acceptable screening test to predict the outcome of the nasal challenge test in patients with non-allergic rhinitis.

Authors:  Luis Santamaría; Ana Calle; Manuela Tejada-Giraldo Biol; Victor Calvo; Jorge Sánchez; Ricardo Cardona
Journal:  World Allergy Organ J       Date:  2020-09-28       Impact factor: 4.084

Review 3.  The Utility of Nasal Challenges to Phenotype Asthma Patients.

Authors:  Guillermo Bentabol-Ramos; Rocio Saenz de Santa Maria-Garcia; Monica Vidal-Diaz; Ibon Eguiluz-Gracia; Almudena Testera-Montes
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

4.  Nasal IgE in subjects with allergic and non-allergic rhinitis.

Authors:  Jonas Eckrich; Julia Hinkel; Anna Fischl; Eva Herrmann; Gabriele Holtappels; Claus Bachert; Stefan Zielen
Journal:  World Allergy Organ J       Date:  2020-06-23       Impact factor: 4.084

Review 5.  Precision Medicine in House Dust Mite-Driven Allergic Asthma.

Authors:  Ibon Eguiluz-Gracia; Francisca Palomares; Maria Salas; Almudena Testera-Montes; Adriana Ariza; Ignacio Davila; Joan Bartra; Cristobalina Mayorga; Maria Jose Torres; Carmen Rondon
Journal:  J Clin Med       Date:  2020-11-26       Impact factor: 4.241

Review 6.  Local Respiratory Allergy: From Rhinitis Phenotype to Disease Spectrum.

Authors:  Almudena Testera-Montes; Maria Salas; Francisca Palomares; Adriana Ariza; María J Torres; Carmen Rondón; Ibon Eguiluz-Gracia
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.